Biofrontera AG: Biofrontera AG receives commitments regarding the acquisition of new shares and convertible bonds

Leverkusen (pta014/01.11.2016/08:45 UTC+1) The Management Board of Biofrontera AG (FSE: B8F) has announced on October 31, 2016, that the registered capital of the company shall be increased against cash contributions by up to 5,012,950 new no-par registered shares with a calculatory participation in the registered capital of EUR 1.00 ("New Shares"). Shareholders are offered the statutory subscription right at a ratio of 6:1 at a subscription price of EUR 3.00 per New Share. The New Shares are entitled to receive dividends from January 1, 2016.

Furthermore, the Management Board has resolved on October 31, 2016, with the approval of the Supervisory Board, to issue up to 49,990 subordinate convertible bonds ("Bonds") with a nominal amount of EUR 100 each and in a total nominal amount of EUR 4,999,000. Shareholders will be offered the statutory subscription right at a ratio of one (1) Bond per 607 old shares at a subscription price of 100 % of the nominal value of EUR 100 per Bond.

Further details are set out in the ad-hoc release pursuant to art. 17 MAR of October 31, 2016, published at 10:29 pm UTC.

The Company has meanwhile received binding commitments from Investors, under which they will undertake to acquire New Shares and/or Bonds in accordance with the communicated terms and conditions in a total amount of EUR 14.8 million.

The Management Board

Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611
Kontakt: Biofrontera AG
Tel.: +49 (0214) 87 63 2 0, Fax.: +49 (0214) 87 63 290
E-mail: press@biofrontera.com

(end)

Emitter:	Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany
Contact Person:	Investor & public relations
Phone:	+49 (0) 214 87 63 20
E-Mail:	press@biofrontera.com
Website:	www.biofrontera.com
ISIN(s):	DE0006046113 (Share)
Stock Exchange(s):	Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart